In clinical trials, tirzepatide users achieved mean reductions of 20.2% compared to 13.7% with semaglutide at 72 weeks
Request a Call Back Was this article helpful
CrossRef Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings Eleonora Galosi, Luca Leonardi, Pietro Falco, Giuseppe Di Pietro, Alessandra Fasolino, Nicoletta Esposito, Caterina Leone, Giulia Di Stefano, Maurizio Inghilleri, Marco Luigetti, Antonini Giovanni, Andrea Truini Amyloid.2023
MZB cells are thought to develop from M B cells but also from T2 B cells 60,61
doi: 10.3892/etm.2017.5106 262 MizunoMMinatoKI